OmniStar Financial Group »

Halozyme Therapeutics shares owned by OmniStar Financial Group

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by OmniStar Financial Group from 13F filings

Historical chart of OmniStar Financial Group investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by OmniStar Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by OmniStar Financial Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $446k 9.3k 47.81
2024-09-30 $880k 15k 57.24

More positions owned by OmniStar Financial Group

Spdr Gold Tr Gold Shs (GLD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Apple (AAPL)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Abrdn Silver Etf Trust Physcl Silvr Shs (SIVR)
Fidelity Merrimack Str Tr Investment Gr Bd (FIGB)
Fidelity Covington Trust Enhanced High Yi (FDHY)
Ssga Active Etf Tr Blackstone Senr (SRLN)
Broadcom (AVGO)
Morgan Stanley Com New (MS)
Oracle Corporation (ORCL)
Kimberly-Clark Corporation (KMB)
Fidelity Covington Trust Qlty Fctor Etf (FQAL)
Altria (MO)

View all positions for OmniStar Financial Group

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Snyder Capital Management
Bank of America Corporation
Alliancebernstein
Geode Capital Management
Macquarie Group
Jpmorgan Chase & Co
Invesco
Congress Asset Management
Dimensional Fund Advisors
Goldman Sachs Group
Northern Trust
Charles Schwab Investment Management

View all funds holding Halozyme Therapeutics